Article ; Online: Editorial comment to activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor.
International journal of urology : official journal of the Japanese Urological Association
2014 Volume 21, Issue 7, Page(s) 741
MeSH term(s) | Carcinoma, Renal Cell/drug therapy ; Female ; Humans ; Imidazoles/therapeutic use ; Indazoles/therapeutic use ; Kidney Neoplasms/drug therapy ; Male ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; Vascular Endothelial Growth Factor Receptor-1/antagonists & inhibitors ; Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors |
---|---|
Chemical Substances | Imidazoles ; Indazoles ; axitinib (C9LVQ0YUXG) ; MTOR protein, human (EC 2.7.1.1) ; TOR Serine-Threonine Kinases (EC 2.7.1.1) ; KDR protein, human (EC 2.7.10.1) ; Vascular Endothelial Growth Factor Receptor-1 (EC 2.7.10.1) ; Vascular Endothelial Growth Factor Receptor-2 (EC 2.7.10.1) |
Language | English |
Publishing date | 2014-07 |
Publishing country | Australia |
Document type | Letter ; Comment |
ZDB-ID | 1328401-0 |
ISSN | 1442-2042 ; 0919-8172 |
ISSN (online) | 1442-2042 |
ISSN | 0919-8172 |
DOI | 10.1111/iju.12423 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4460: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 278: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.